Literature DB >> 11795841

A statistical interpretive method for neuropsychological test data.

L S Miller1, M L Rohling.   

Abstract

The accurate interpretation of large numbers of neuropsychological tests within a flexible battery approach is a difficult and sometimes controversial process. We present a statistically based method of interpretation (Rohling's Interpretive Method or RIM) and evaluation of neuropsychological data that allows for varying numbers of tests along a varying number of cognitive domains, yet remains psychometrically based. This method requires informed clinical judgment in that the level of confidence for tests, cognitive domains, and global indices are used as the backdrop for interpretive decisions. Specific procedures for use are presented in a systematic, detailed fashion to allow the interested reader to replicate the method. Two case examples are presented: a straightforward case of cerebrovascular insult and a more complicated case of mixed etiology. Examples include a variety of different neuropsychological tests commonly used in a flexible battery approach. A discussion of the practicality, ease of use, and potential limitations of this method are further presented.

Entities:  

Mesh:

Year:  2001        PMID: 11795841     DOI: 10.1023/a:1016602708066

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  20 in total

Review 1.  A neuropsychological approach to intelligence.

Authors:  A Ardila
Journal:  Neuropsychol Rev       Date:  1999-09       Impact factor: 7.444

2.  Ten-year follow-up survey of clinical neuropsychologists: part I. Practices and beliefs.

Authors:  J J Sweet; P J Moberg; Y Suchy
Journal:  Clin Neuropsychol       Date:  2000-02       Impact factor: 3.535

3.  Factor structure of the Wechsler memory scale-revised in relation to age and educational level.

Authors:  R A Bornstein; G J Chelune
Journal:  Arch Clin Neuropsychol       Date:  1989       Impact factor: 2.813

4.  Convergent and discriminant validation by the multitrait-multimethod matrix.

Authors:  D T CAMPBELL; D W FISKE
Journal:  Psychol Bull       Date:  1959-03       Impact factor: 17.737

Review 5.  Clinical versus actuarial judgment.

Authors:  R M Dawes; D Faust; P E Meehl
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

6.  Construct validity of neuropsychological tests of conceptual and attentional abilities.

Authors:  J P O'Donnell; L A Macgregor; J J Dabrowski; J M Oestreicher; J J Romero
Journal:  J Clin Psychol       Date:  1994-07

7.  Judgement research and neuropsychological assessment: a narrative review and meta-analyses.

Authors:  H N Garb; C J Schramke
Journal:  Psychol Bull       Date:  1996-07       Impact factor: 17.737

8.  Illusory correlation as an obstacle to the use of valid psychodiagnostic signs.

Authors:  L J Chapman; J P Chapman
Journal:  J Abnorm Psychol       Date:  1969-06

9.  Impediments to accurate clinical judgment and possible ways to minimize their impact.

Authors:  H R Arkes
Journal:  J Consult Clin Psychol       Date:  1981-06

10.  The Rey AVLT recognition memory task measures motivational impairment after mild head trauma.

Authors:  L M Binder; M R Villanueva; D Howieson; R T Moore
Journal:  Arch Clin Neuropsychol       Date:  1993-03       Impact factor: 2.813

View more
  14 in total

1.  Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.

Authors:  April D Thames; Zanjbeel Mahmood; Alison C Burggren; Ahoo Karimian; Taylor P Kuhn
Journal:  AIDS Care       Date:  2015-12-23

2.  A critique of Miller and Rohling's statistical interpretive method for neuropsychological test data.

Authors:  Victor L Willson; Cecil R Reynolds
Journal:  Neuropsychol Rev       Date:  2004-09       Impact factor: 7.444

3.  Rohling's Interpretive Method and inherent limitations on the flexibility of "flexible batteries".

Authors:  Barton W Palmer; Mark I Appelbaum; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2004-09       Impact factor: 7.444

4.  Education quality, reading recognition, and racial differences in the neuropsychological outcome from traumatic brain injury.

Authors:  Noah D Silverberg; Robin A Hanks; Season C Tompkins
Journal:  Arch Clin Neuropsychol       Date:  2013-08       Impact factor: 2.813

5.  Validation of an integrated method for determining cognitive ability: Implications for routine assessments and clinical trials.

Authors:  Olivier Godefroy; Laura Gibbons; Momar Diouf; David Nyenhuis; Martine Roussel; Sandra Black; Jean Marc Bugnicourt
Journal:  Cortex       Date:  2014-02-07       Impact factor: 4.027

6.  Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults.

Authors:  April D Thames; Taylor P Kuhn; Timothy J Williamson; Jacob D Jones; Zanjbeel Mahmood; Andrea Hammond
Journal:  Drug Alcohol Depend       Date:  2016-11-14       Impact factor: 4.492

7.  Cannabis use and neurocognitive functioning in a non-clinical sample of users.

Authors:  April D Thames; Natalie Arbid; Philip Sayegh
Journal:  Addict Behav       Date:  2014-02-06       Impact factor: 3.913

Review 8.  Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.

Authors:  Noah D Silverberg; Paul K Crane; Kristen Dams-O'Connor; James Holdnack; Brian J Ivins; Rael T Lange; Geoffrey T Manley; Michael McCrea; Grant L Iverson
Journal:  J Neurotrauma       Date:  2016-06-27       Impact factor: 5.269

9.  Effects of Sleep Health on Cognitive Function in HIV+ and HIV- Adults.

Authors:  Zanjbeel Mahmood; Andrea Hammond; Rodolfo A Nunez; Michael R Irwin; April D Thames
Journal:  J Int Neuropsychol Soc       Date:  2018-08-31       Impact factor: 2.892

10.  The Impact of Using Different Reference Populations on Measurement of Breast Cancer-Related Cognitive Impairment Rates.

Authors:  Jonathan D Clapp; George Luta; Brent J Small; Tim A Ahles; James C Root; Deena Graham; Arti Hurria; Paul B Jacobsen; Heather Jim; Brenna C McDonald; Robert A Stern; Andrew J Saykin; Jeanne S Mandelblatt
Journal:  Arch Clin Neuropsychol       Date:  2018-12-01       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.